about
Regenerative Medicine Strategies for Esophageal RepairStructure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulantsIdentification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by x-ray crystallographyA familial factor XIII subunit B deficiencyDifference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.Our ancient heritage in blood clotting and some of its consequences.Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.The accelerating effect of calcium and other cations on the conversion of fibrinogen to fibrinAn accelerating property of plasma for the coagulation of fibrinogen by thrombinEffects of thrombin and platelet concentrations and of clot retraction on fibrin strand widths.A brief historical review of the waterfall/cascade of blood coagulation.EFFECTS OF THROMBIN ON THE POTASSIUM AND ATP CONTENT OF PLATELETSA double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa.The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.Normal and abnormal hemostasis--an integrated view. A reviewInvolvement of transglutaminase in myofibril assembly of chick embryonic myoblasts in culture.The conversion of fibrinogen to fibrin. XIII. Dissolution of fibrin and inhibition of clotting by various neutral saltsHeterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.A new transglutaminase-like from the ascidian Ciona intestinalis.Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiency.Current understanding in diagnosis and management of factor XIII deficiency.Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.Newly-Recognized Roles of Factor XIII in Thrombosis.Cross-linking of fibrin by fibrin=stabilizing factor.Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.Selected topics on blood coagulation.Biochemical studies on the phenomenon of virus reproduction. III. The inhibition of coliphage T2r+ multiplication by sodium salicylate and sodium gentisate.THE EFFECT OF CALCIUM OF FIBRINOLYSIS IN VITRO.Congenital factor XIII deficiency: a patient report and review of the literature.The N-terminal residues of bovine plasma clot.Transglutaminase in neurological disease.Identification of a FXIIIA variant in human neuroblastoma cell lines.Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations.Documentation of the plasma factor XIII deficiency in man.Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody.Plasminogen Activator Inhibitor-1 Reduces tPA-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.[Factor XIII : Pharmacodynamic and pharmacokinetic characteristics].
P2860
Q27027551-A9DBB5D7-0B1A-45EB-8222-F3A0C6252DB1Q27687108-55969A61-8C46-4AE2-9BAE-3DB967A52E51Q27766891-F125036A-0299-4FAD-B1F3-7848A7F79A83Q28114814-EF59A98B-F65B-44B5-B6B6-97641F697E63Q30430667-D1269DBC-40F7-4D1F-A0AC-A606E092A430Q33470847-3FEC5EEE-FC3A-44AA-93E8-FD7A02F8103BQ34063063-EB88542B-DCCF-4B3B-A6A3-847C75FDC327Q34211321-86E7E264-3ED2-4BB0-AE4D-BE576C15B664Q34517341-5FAABF61-0FAC-4BF2-8482-19A85389E34AQ35263602-2769CD86-F371-498C-9D46-69BE0423D51FQ35270958-61C3614F-C591-457D-AA42-AB8DB438E0FBQ35280836-2277DF58-37C0-48A8-892A-49E125ED1D41Q35564946-BE965C11-32AE-41CC-911C-B2E2FAD55552Q35570266-1C17C3EF-D374-4C52-8EC9-DD1BA21A5A0CQ35739203-36F1DB52-95D8-420B-BC64-922CADE857C3Q35863142-137412F6-6A80-4D27-B4ED-6B34B10687ADQ36058696-0A8BCAE5-7BBD-4DA6-A55C-1AC71513AA33Q36235966-C6FCE365-F136-491A-B364-0E0BF83A7454Q36286749-7C02C808-3529-46C0-8F98-8F80FC643E28Q36459685-95F10F0C-2A89-46BD-A945-CB789574A3ABQ36865949-67AB2F8A-48E6-41F0-8397-5A35DF74B13EQ37473269-E1A9C9B5-792F-46E2-B5D0-D9A9C5FA3B0BQ37560127-DAA2BE1F-7898-4C6E-ADB8-21D863E225DAQ37899674-C5C46719-3BDD-4F7A-AC4F-48564EC008B2Q38801273-3F97CE77-E53A-406F-93AE-39CE86288CF0Q39920824-E1D51C56-C89D-4410-AB06-BF4D1366C6CFQ39920829-9736A3C4-D0ED-4A57-BE8D-306A93C9105EQ39948297-EB79A6E1-2B5F-45A3-9BA6-C2C9734BA0DEQ40757024-03CE203D-2841-4F1D-8CC5-B6ED943D49D7Q41294595-6AFD2968-901F-44A3-BC5A-054B6ACC9153Q41328280-4D5C5937-2E11-4E31-8E9E-DCF24AC6A6E2Q41981441-212B3300-78F6-4B74-BB84-9DEC51BD8B9DQ42357162-071AD0C1-7F14-4BDA-93CA-9CF4B724BF76Q43066425-AF5DF775-97A4-46F5-9D3E-E88DDC58F72EQ43865957-EDF8863D-2166-4270-B946-43B46F6D019DQ46392791-606FD2B3-43DD-4528-9933-EA3DF307CDD5Q46446477-4C7EB8D7-EDBB-4FA2-B88C-C94B40169A28Q48034572-A06D3F6C-2EEC-4EF3-BFE7-5D50BF066A5DQ49897021-EEABB32A-6410-4DA7-95C3-B1D077B2A43BQ51016864-198F54A1-B5B1-47ED-A807-3ECEF56F8CC5
P2860
description
1948 nî lūn-bûn
@nan
1948 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1948 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1948年の論文
@ja
1948年論文
@yue
1948年論文
@zh-hant
1948年論文
@zh-hk
1948年論文
@zh-mo
1948年論文
@zh-tw
1948年论文
@wuu
name
On the Solubility of Fibrin Clots.
@ast
On the Solubility of Fibrin Clots.
@en
On the Solubility of Fibrin Clots.
@nl
type
label
On the Solubility of Fibrin Clots.
@ast
On the Solubility of Fibrin Clots.
@en
On the Solubility of Fibrin Clots.
@nl
prefLabel
On the Solubility of Fibrin Clots.
@ast
On the Solubility of Fibrin Clots.
@en
On the Solubility of Fibrin Clots.
@nl
P1433
P1476
On the Solubility of Fibrin Clots.
@en
P356
10.1126/SCIENCE.108.2802.280
P407
P577
1948-09-01T00:00:00Z